As we roll into 2019, we highlight some trends to watch. Additional detail available at Evaluate.com’s Vantage 2019 Previewfor an industry-wide analysis.
As we highlighted in our 2018 updates another potentially very valuable but elusive therapy area is Alzheimer’s disease, and next year will undoubtedly contain updates. We list 23 investigational drugs for Alzheimer's disease in our knowledgebase.
Regarding upcoming potential budget busters, there are fifteen investigational drugs with PDUFA Dates between January and Sept 2019. Eight of these drugs have priority designations. Take a look at our “Monitoring Drugs with PDUFA Dates” Use Caseto see how the Prescribe Right Pharmaceutical Pipeline Tracker can keep you on top of these drugs.
And from the week ending January 5, 2019:
Stay informed, subscribe to the
Prescribe Right Pharmaceutical Pipeline Tracker
Latest Tweets from Prescribe Right